DCE-MRI in clinical trials: data acquisition techniques and analysis methods.

International journal of clinical pharmacology and therapeutics

Volumn 41, Issue 12, 2003, Pages 603-605

  Strecker, R ^a   Scheffler, K ^a   Buchert M ^a   Mross, K ^a   Drevs, J ^a   Hennig, J ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM; RADIOISOTOPE;

CLINICAL TRIAL; HUMAN; INFORMATION PROCESSING; METHODOLOGY; NEOPLASM; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PHASE 1 CLINICAL TRIAL; REVIEW; SCINTISCANNING; STATISTICS; THREE DIMENSIONAL IMAGING;

ANGIOGENESIS INHIBITORS; CLINICAL TRIALS; CLINICAL TRIALS, PHASE I; CONTRAST MEDIA; DATA COLLECTION; GADOLINIUM; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; NEOPLASMS; RADIOISOTOPES; STATISTICS;

EID: 1542646983     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP41603     Document Type: Review

References (8)